- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
「7 Consecutive Wins Address Since November 21st」 liquidated a 500 BTC short position 2 hours ago, losing $448,000.
Yi Li Hua: The 60-day bear market in the crypto market may be coming to an end, with a continued positive outlook for the future market.
ENA Surges Over 16% in 24 Hours, Currently Trading at $0.2774
James Wynn went long on BTC with 40x leverage yesterday, currently holding a unrealized profit of $231,000.
Stable Mainnet will launch on December 8th at 9:00 PM.
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App